183 related articles for article (PubMed ID: 38542998)
1. Drug Repositioning via Graph Neural Networks: Identifying Novel JAK2 Inhibitors from FDA-Approved Drugs through Molecular Docking and Biological Validation.
Yasir M; Park J; Han ET; Park WS; Han JH; Chun W
Molecules; 2024 Mar; 29(6):. PubMed ID: 38542998
[TBL] [Abstract][Full Text] [Related]
2. Vismodegib Identified as a Novel COX-2 Inhibitor via Deep-Learning-Based Drug Repositioning and Molecular Docking Analysis.
Yasir M; Park J; Han ET; Park WS; Han JH; Kwon YS; Lee HJ; Chun W
ACS Omega; 2023 Sep; 8(37):34160-34170. PubMed ID: 37744812
[TBL] [Abstract][Full Text] [Related]
3. Machine Learning-Based Drug Repositioning of Novel Janus Kinase 2 Inhibitors Utilizing Molecular Docking and Molecular Dynamic Simulation.
Yasir M; Park J; Han ET; Park WS; Han JH; Kwon YS; Lee HJ; Chun W
J Chem Inf Model; 2023 Nov; 63(21):6487-6500. PubMed ID: 37906702
[TBL] [Abstract][Full Text] [Related]
4. SNF-NN: computational method to predict drug-disease interactions using similarity network fusion and neural networks.
Jarada TN; Rokne JG; Alhajj R
BMC Bioinformatics; 2021 Jan; 22(1):28. PubMed ID: 33482713
[TBL] [Abstract][Full Text] [Related]
5. A geometric deep learning framework for drug repositioning over heterogeneous information networks.
Zhao BW; Su XR; Hu PW; Ma YP; Zhou X; Hu L
Brief Bioinform; 2022 Nov; 23(6):. PubMed ID: 36125202
[TBL] [Abstract][Full Text] [Related]
6. Combined deep learning and molecular docking simulations approach identifies potentially effective FDA approved drugs for repurposing against SARS-CoV-2.
Anwaar MU; Adnan F; Abro A; Khan RA; Rehman AU; Osama M; Rainville C; Kumar S; Sterner DE; Javed S; Jamal SB; Baig A; Shabbir MR; Ahsan W; Butt TR; Assir MZ
Comput Biol Med; 2022 Feb; 141():105049. PubMed ID: 34823857
[TBL] [Abstract][Full Text] [Related]
7. Predicting Potential SARS-COV-2 Drugs-In Depth Drug Database Screening Using Deep Neural Network Framework SSnet, Classical Virtual Screening and Docking.
Karki N; Verma N; Trozzi F; Tao P; Kraka E; Zoltowski B
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557253
[TBL] [Abstract][Full Text] [Related]
8. Attention Mechanism-Based Graph Neural Network Model for Effective Activity Prediction of SARS-CoV-2 Main Protease Inhibitors: Application to Drug Repurposing as Potential COVID-19 Therapy.
Wu Y; Li K; Li M; Pu X; Guo Y
J Chem Inf Model; 2023 Nov; 63(22):7011-7031. PubMed ID: 37960886
[TBL] [Abstract][Full Text] [Related]
9. Drug repositioning based on the heterogeneous information fusion graph convolutional network.
Cai L; Lu C; Xu J; Meng Y; Wang P; Fu X; Zeng X; Su Y
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34378011
[TBL] [Abstract][Full Text] [Related]
10. Artificial intelligence to deep learning: machine intelligence approach for drug discovery.
Gupta R; Srivastava D; Sahu M; Tiwari S; Ambasta RK; Kumar P
Mol Divers; 2021 Aug; 25(3):1315-1360. PubMed ID: 33844136
[TBL] [Abstract][Full Text] [Related]
11. A transferable deep learning approach to fast screen potential antiviral drugs against SARS-CoV-2.
Wang S; Sun Q; Xu Y; Pei J; Lai L
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34081143
[TBL] [Abstract][Full Text] [Related]
12. MSGNN-DTA: Multi-Scale Topological Feature Fusion Based on Graph Neural Networks for Drug-Target Binding Affinity Prediction.
Wang S; Song X; Zhang Y; Zhang K; Liu Y; Ren C; Pang S
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176031
[TBL] [Abstract][Full Text] [Related]
13. Identification of new potential candidates to inhibit EGF via machine learning algorithm.
Torabi M; Yasami-Khiabani S; Sardari S; Golkar M; Pérez-Sánchez H; Ghasemi F
Eur J Pharmacol; 2024 Jan; 963():176176. PubMed ID: 38000720
[TBL] [Abstract][Full Text] [Related]
14. Discovering the Active Ingredients of Medicine and Food Homologous Substances for Inhibiting the Cyclooxygenase-2 Metabolic Pathway by Machine Learning Algorithms.
Tian Y; Zhang Z; Yan A
Molecules; 2023 Sep; 28(19):. PubMed ID: 37836625
[TBL] [Abstract][Full Text] [Related]
15. Drug repositioning based on weighted local information augmented graph neural network.
Meng Y; Wang Y; Xu J; Lu C; Tang X; Peng T; Zhang B; Tian G; Yang J
Brief Bioinform; 2023 Nov; 25(1):. PubMed ID: 38019732
[TBL] [Abstract][Full Text] [Related]
16. A deep learning and docking simulation-based virtual screening strategy enables the rapid identification of HIF-1α pathway activators from a marine natural product database.
A R N; G K R
J Biomol Struct Dyn; 2024; 42(2):629-651. PubMed ID: 37038705
[TBL] [Abstract][Full Text] [Related]
17. DLDTI: a learning-based framework for drug-target interaction identification using neural networks and network representation.
Zhao Y; Zheng K; Guan B; Guo M; Song L; Gao J; Qu H; Wang Y; Shi D; Zhang Y
J Transl Med; 2020 Nov; 18(1):434. PubMed ID: 33187537
[TBL] [Abstract][Full Text] [Related]
18. Identification of thrombopoiesis inducer based on a hybrid deep neural network model.
Mo Q; Zhang T; Wu J; Wang L; Luo J
Thromb Res; 2023 Jun; 226():36-50. PubMed ID: 37119555
[TBL] [Abstract][Full Text] [Related]
19. Drug repositioning of COVID-19 based on mixed graph network and ion channel.
Wang X; Li Q; Liu Y; Du Z; Jin R
Math Biosci Eng; 2022 Jan; 19(4):3269-3284. PubMed ID: 35341251
[TBL] [Abstract][Full Text] [Related]
20. DeepNC: a framework for drug-target interaction prediction with graph neural networks.
Tran HNT; Thomas JJ; Ahamed Hassain Malim NH
PeerJ; 2022; 10():e13163. PubMed ID: 35578674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
